Skip to content

Shiying Yuan

4 papers in the library · 16 citations · publishing 2024-2026

Papers

Sort Most recent Most cited

Pleiotropic modulation of the gut-brain-lung axis by ketamine and its enantiomers.

Molecular Psychiatry April 13, 2026 Xin Zhao, Xinyu Zhang, Shiying Yuan et al.

Ketamine, a potent N-methyl-D-aspartate receptor (NMDAR) antagonist, is widely used for anesthesia and analgesia and, because of its rapid antidepressant effects, in psychiatry. Increasing evidence suggests that ketamine and its enantiomers-(R)-ketamine (arketamine) and (S)-ketamine (esketamine)-also modulate systemic immunity and provide organ protection, partly through interactions with the...

Intestinal γδ T17-IL-17A signaling disrupts hippocampal mitophagy in stress-induced depression and is restored by arketamine.

Journal of Neuroinflammation December 18, 2025 Mengqi Han, Bing Xie, Yuan Yu et al.

Chronic stress precipitates depression, yet how gut-immune-brain interactions translate stress into mood pathology remains unclear. We tested the hypothesis that stress-primed small intestinal γδ T cells drive hippocampal mitochondrial dysfunction and depression-like behavior via interleukin-17A (IL-1A). In mice exposed to chronic restraint stress (CRS), we combined behavioral assays...

Efficacy and safety of esketamine for emergency endotracheal intubation in ICU patients: a double-blind, randomized controlled clinical trial.

Scientific Reports February 19, 2025 Xue Zhang, Xin Zhao, Jiaxin Xu et al. 8 citations

Emergency endotracheal intubation in critically ill patients are dangerous procedures with a greater risk of severe hypotension The efficacy and safety of esketamine with sympathoexcitatory effects for rapid sequence induction in critically ill patients remain unclear. In this prospective double-blinded randomized controlled trial, adult patients were randomly assigned to receive either...

DOI: 10.1038/s41598-025-91016-w (opens in new tab) Full text (opens in new tab) Anesthesia induction Emergency endotracheal intubation Hypotension Intensive care +9

Psychoactive substances for the treatment of neuropsychiatric disorders.

Asian Journal of Psychiatry November 1, 2024 Zifan Zhen, Xueqiang Sun, Shiying Yuan et al. 8 citations

In the contemporary landscape of psychiatric medicine, critical advancements have been noted in the utilization of psychoactive substances such as hallucinogens, 3,4-methylenedioxymethamphetamine (MDMA), and ketamine for the treatment of severe mental health disorders. This review provides a detailed evaluation of these substances, focusing on their mechanisms of action and the profound...

DOI: 10.1016/j.ajp.2024.104193 (opens in new tab) Full text (opens in new tab) Ketamine MDMA Neuropsychiatric disorders Psychedelics hallucinogens +6